Blinatumomab: for acute lymphoblastic leukemia
Blinatumomab is an injectable drug that acts as an antibody, joins the membranes of cancer cells and allows the immune system to identify them more easily; as a result, defense cells are easier to remove cancer cells, especially in cases of acute lymphoblastic disease.Leukemia. This medicine can also be known commercially as Blincyto and should […]